AAAAAA

   
Results: 1-12 |
Results: 12
EPOXYBUTENE-HEMOGLOBIN ADDUCTS IN RATS AND MICE - DOSE-RESPONSE FOR FORMATION AND PERSISTENCE DURING AND FOLLOWING LONG-TERM LOW-LEVEL EXPOSURE TO BUTADIENE
Authors: OSTERMANGOLKAR SM MOSS O JAMES A BRYANT MS TURNER M BOND JA
Citation: Sm. Ostermangolkar et al., EPOXYBUTENE-HEMOGLOBIN ADDUCTS IN RATS AND MICE - DOSE-RESPONSE FOR FORMATION AND PERSISTENCE DURING AND FOLLOWING LONG-TERM LOW-LEVEL EXPOSURE TO BUTADIENE, Toxicology and applied pharmacology, 150(1), 1998, pp. 166-173
INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE - 4-AMIDO, 4-CARBAMOYL, AND 4-CARBOXAMIDO DERIVATIVES OF ENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDIN-11-YL)PIPERAZINE AND ENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDIN-11-YL)PIPERAZINE
Authors: MALLAMS AK ROSSMAN RR DOLL RJ GIRIJAVALLABHAN VM GANGULY AK PETRIN J WANG L PATTON R BISHOP WR CARR DM KIRSCHMEIER P CATINO JJ BRYANT MS CHEN KJ KORFMACHER WA NARDO C WANG SY NOMEIR AA LIN CC LI ZJ CHEN JP LEE S DELL J LIPARI P MALKOWSKI M YAREMKO B KING I LIU M
Citation: Ak. Mallams et al., INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE - 4-AMIDO, 4-CARBAMOYL, AND 4-CARBOXAMIDO DERIVATIVES OF ENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDIN-11-YL)PIPERAZINE AND ENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDIN-11-YL)PIPERAZINE, Journal of medicinal chemistry, 41(6), 1998, pp. 877-893
-PIPERIDINYL]-2-OXO-ETHYL]-1-PIPERIDINECARBOXAMIDE (SCH-66336) - A VERY POTENT FARNESYL-PROTEIN TRANSFERASE INHIBITOR AS A NOVEL ANTITUMOR AGENT())
Authors: NJOROGE FG TAVERAS AG KELLY J REMISZEWSKI S MALLAMS AK WOLIN R AFONSO A COOPER AB RANE DF LIU YT WONG J VIBULBHAN B PINTO P DESKUS J ALVAREZ CS DELROSARIO J CONNOLLY M WANG J DESAI J ROSSMAN RR BISHOP WR PATTON R WANG L KIRSCHMEIER P BRYANT MS NOMEIR AA LIN CC LIU M MCPHAIL AT DOLL RJ GIRIJAVALLABHAN VM GANGULY AK
Citation: Fg. Njoroge et al., -PIPERIDINYL]-2-OXO-ETHYL]-1-PIPERIDINECARBOXAMIDE (SCH-66336) - A VERY POTENT FARNESYL-PROTEIN TRANSFERASE INHIBITOR AS A NOVEL ANTITUMOR AGENT()), Journal of medicinal chemistry, 41(24), 1998, pp. 4890-4902
POTENT, SELECTIVE, AND ORALLY BIOAVAILABLE TRICYCLIC PYRIDYL ACETAMIDE N-OXIDE INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE WITH ENHANCED IN-VIVO ANTITUMOR-ACTIVITY
Authors: NJOROGE FG VIBULBHAN B PINTO P BISHOP WR BRYANT MS NOMEIR AA LIN CC LIU M DOLL RJ GIRIJAVALLABHAN V GANGULY AK
Citation: Fg. Njoroge et al., POTENT, SELECTIVE, AND ORALLY BIOAVAILABLE TRICYCLIC PYRIDYL ACETAMIDE N-OXIDE INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE WITH ENHANCED IN-VIVO ANTITUMOR-ACTIVITY, Journal of medicinal chemistry, 41(10), 1998, pp. 1561-1567
ANTITUMOR-ACTIVITY OF SCH-66336, AN ORALLY BIOAVAILABLE TRICYCLIC INHIBITOR OF FARNESYL-PROTEIN TRANSFERASE, IN HUMAN TUMOR XENOGRAFT MODELS AND WAP-RAS TRANSGENIC MICE
Authors: LIU M BRYANT MS CHEN JP LEE SN YAREMKO B LIPARI P MALKOWSKI M FERRARI E NIELSEN L PRIOLI N DELL J SINHA D SYED J KORFMACHER WA NOMEIR AA LIN CC WANG L TAVERAS AG DOLL RJ NJOROGE FG MALLAMS AK REMISZEWSKI S CATINO JJ GIRIJAVALLABHAN VM KIRSCHMEIER P BISHOP WR
Citation: M. Liu et al., ANTITUMOR-ACTIVITY OF SCH-66336, AN ORALLY BIOAVAILABLE TRICYCLIC INHIBITOR OF FARNESYL-PROTEIN TRANSFERASE, IN HUMAN TUMOR XENOGRAFT MODELS AND WAP-RAS TRANSGENIC MICE, Cancer research, 58(21), 1998, pp. 4947-4956
PHARMACOKINETIC SCREENING FOR THE SELECTION OF NEW DRUG DISCOVERY CANDIDATES IS GREATLY ENHANCED THROUGH THE USE OF LIQUID-CHROMATOGRAPHY ATMOSPHERIC-PRESSURE IONIZATION TANDEM MASS-SPECTROMETRY
Authors: BRYANT MS KORFMACHER WA WANG SY NARDO C NOMEIR AA LIN CC
Citation: Ms. Bryant et al., PHARMACOKINETIC SCREENING FOR THE SELECTION OF NEW DRUG DISCOVERY CANDIDATES IS GREATLY ENHANCED THROUGH THE USE OF LIQUID-CHROMATOGRAPHY ATMOSPHERIC-PRESSURE IONIZATION TANDEM MASS-SPECTROMETRY, Journal of chromatography, 777(1), 1997, pp. 61-66
HPLC-API MS/MS - A POWERFUL TOOL FOR INTEGRATING DRUG-METABOLISM INTOTHE DRUG DISCOVERY PROCESS/
Authors: KORFMACHER WA COX KA BRYANT MS VEALS J NG K WATKINS R LIN CC
Citation: Wa. Korfmacher et al., HPLC-API MS/MS - A POWERFUL TOOL FOR INTEGRATING DRUG-METABOLISM INTOTHE DRUG DISCOVERY PROCESS/, Drug discovery today, 2(12), 1997, pp. 532-537
STRUCTURE-ACTIVITY RELATIONSHIP OF 3-SUBSTITUTED ,6]CYCLOHEPTA[1,2-B]PYRIDIN-11-YLIDENE)-PIPERIDINE INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE - DESIGN AND SYNTHESIS OF IN-VIVO ACTIVE ANTITUMOR COMPOUNDS
Authors: NJOROGE FG VIBULBHAN B RANE DF BISHOP WR PETRIN J PATTON R BRYANT MS CHEN KJ NOMEIR AA LIN CC LIU M KING I CHEN JP LEE SN YAREMKO B DELL J LIPARI P MALKOWSKI M LI ZJ CATINO J DOLL RJ GIRIJAVALLABHAN V GANGULY AK
Citation: Fg. Njoroge et al., STRUCTURE-ACTIVITY RELATIONSHIP OF 3-SUBSTITUTED ,6]CYCLOHEPTA[1,2-B]PYRIDIN-11-YLIDENE)-PIPERIDINE INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE - DESIGN AND SYNTHESIS OF IN-VIVO ACTIVE ANTITUMOR COMPOUNDS, Journal of medicinal chemistry, 40(26), 1997, pp. 4290-4301
IMMUNOGENICITY OF AMEBIC ANTIGENS IN RAINBOW-TROUT, ONCORHYNCHUS-MYKISS (WALBAUM)
Authors: BRYANT MS LESTER RJG WHITTINGTON RJ
Citation: Ms. Bryant et al., IMMUNOGENICITY OF AMEBIC ANTIGENS IN RAINBOW-TROUT, ONCORHYNCHUS-MYKISS (WALBAUM), Journal of fish diseases, 18(1), 1995, pp. 9-19
2,6-DIMETHYLANILINE HEMOGLOBIN ADDUCTS FROM LIDOCAINE IN HUMANS
Authors: BRYANT MS SIMMONS HF HARRELL RE HINSON JA
Citation: Ms. Bryant et al., 2,6-DIMETHYLANILINE HEMOGLOBIN ADDUCTS FROM LIDOCAINE IN HUMANS, Carcinogenesis, 15(10), 1994, pp. 2287-2290
ANALYSIS OF 4-AMINOBIPHENYL-DNA ADDUCTS IN HUMAN URINARY-BLADDER AND LUNG BY ALKALINE-HYDROLYSIS AND NEGATIVE-ION GAS-CHROMATOGRAPHY MASS-SPECTROMETRY
Authors: LIN DX LAY JO BRYANT MS MALAVEILLE C FRIESEN M BARTSCH H LANG NP KADLUBAR FF
Citation: Dx. Lin et al., ANALYSIS OF 4-AMINOBIPHENYL-DNA ADDUCTS IN HUMAN URINARY-BLADDER AND LUNG BY ALKALINE-HYDROLYSIS AND NEGATIVE-ION GAS-CHROMATOGRAPHY MASS-SPECTROMETRY, Environmental health perspectives, 102, 1994, pp. 11-16
DETECTION AND CHARACTERIZATION OF DNA ADDUCTS AT THE FEMTOMOLE LEVEL BY DESORPTION IONIZATION MASS-SPECTROMETRY
Authors: LAY JO CHIARELLI MP BRYANT MS NELSON RW
Citation: Jo. Lay et al., DETECTION AND CHARACTERIZATION OF DNA ADDUCTS AT THE FEMTOMOLE LEVEL BY DESORPTION IONIZATION MASS-SPECTROMETRY, Environmental health perspectives, 99, 1993, pp. 191-193
Risultati: 1-12 |